.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
Accenture
Healthtrust
Deloitte
Cantor Fitzgerald
Medtronic

Generated: July 25, 2017

DrugPatentWatch Database Preview

VERSED Drug Profile

« Back to Dashboard

Which patents cover Versed, and what generic Versed alternatives are available?

Versed is a drug marketed by Roche and HLR and is included in two NDAs.

The generic ingredient in VERSED is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.

Summary for Tradename: VERSED

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list26
Clinical Trials: see list66
Patent Applications: see list762
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VERSED at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche
VERSED
midazolam hydrochloride
SYRUP;ORAL020942-001Oct 15, 1998DISCNYesNo► Subscribe► Subscribe► Subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-002May 26, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-001Dec 20, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VERSED

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
VERSED
midazolam hydrochloride
SYRUP;ORAL020942-001Oct 15, 1998► Subscribe► Subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-001Dec 20, 1985► Subscribe► Subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-002May 26, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Fish and Richardson
Chubb
QuintilesIMS
Express Scripts
Fuji
Farmers Insurance
Queensland Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot